Observational studyMedicine2019

A retrospective observational study of early experiences of vedolizumab treatment for inflammatory bowel disease in the UK: The REVIVE study.

Fraser Cummings et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.